0 items USD 0.00Search
Your search for "globaldata neogenomics inc ngnm pharmaceuticals healthcare deals alliances profile" gave back 1456334 results.
Automotive Industry Themes: Autonomy, shared mobility, solid state batteries, vehicle light weighting and M&A Summary The automotive industry is...
Catalog:
MarketLine
September 2019
Price: USD 1,495.00
Noninvasive Cancer Diagnostics Technology is a process for the detection of disease through minimal incisions into the body. Noninvasive cancer...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The global liquid biopsy market is predicted to surpass US$ 11 Billion by 2030. The advantages of liquid biopsy over solid tumor biopsy, rising...
Catalog:
iGATE
June 2022
Price: USD 3,490.00
The global Kidney Cancer Diagnosis market is projected to reach US$ 686.6 million in 2029, increasing from US$ 465.5 million in 2022, with the CAGR...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Pharmaceutical Deal Trends (2010–2015) and In-Depth Analysis of Recent Deal Activity Summary GBI Research’s latest report, "Pharmaceutical Deal...
CBR Pharma Insights
October 2015
Price: USD 2,995.00
The global Hematologic Malignancies Testing market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The global Minimal Residual Disease (MRD) Testing market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the...
Catalog:
GIR
August 2023
Price: USD 4,480.00
Somatic mutation analysis is a standard of practice for tumors in order to identify therapeutic sensitizing and resistance mutations. This allows a...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Somatic mutation analysis is a standard of practice for tumors in order to identify therapeutic sensitizing and resistance mutations. This allows a...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Hematologic Malignancies Testing market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the...
Catalog:
GIR
March 2023
Price: USD 4,480.00
The global Lung Cancer Genomic Testing market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of %...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
Highlights The global PARP Inhibitor Biomarkers Service market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
The global Minimal Residual Disease (MRD) Testing market size was valued at US$ million in 2022. With growing demand in downstream market and...
Catalog:
LPI
August 2023
Price: USD 3,660.00
The “PARP Inhibitor Biomarkers Service Industry Forecast” looks at past sales and reviews total world PARP Inhibitor Biomarkers Service sales in 2022...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The “Anatomic Pathology Industry Forecast” looks at past sales and reviews total world Anatomic Pathology sales in 2022, providing a comprehensive...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Filter By Report Date
Filter By Industry
Filter By Country
- (-) Remove Global filter Global
- Latin America (4) Apply Latin America filter
- Middle East (3) Apply Middle East filter
- Africa (2) Apply Africa filter
- America (1) Apply America filter
- Americas (1) Apply Americas filter
- Asia (1) Apply Asia filter
- BRIC (1) Apply BRIC filter
- Caribbean (1) Apply Caribbean filter
- Oceania (1) Apply Oceania filter
